Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,203 public trials 3,225 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

NCT07079631

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Yale University New Haven, Connecticut, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 14 locations
View Trial Details
Recruiting

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

NCT07265674

Conditions
Adenocarcinoma, Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC), +12 more
Locations
  • City of Hope (Site 107) Duarte, California, United States
  • University of California at Irvine (Site 101) Orange, California, United States
  • UCLA Medical Center (Site 117) Santa Monica, California, United States
  • Moffitt Cancer Center Magnolia Campus (Site 123) Tampa, Florida, United States
View all 18 locations
View Trial Details
Recruiting

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07450859

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Siteman Cancer Center (Washington University School of Medicine) St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center - Main Campus New York, United States
  • Thomas Jefferson University, Sidney Kimmel Comprensive Cancer Center, Clinical Trials Office Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

NCT07176312

Conditions
Digestive System Diseases, Digestive System Neoplasms, First Line Therapy, +14 more
Locations
  • Charité CVK Berlin, Germany
  • Vivantes Klinikum im Friedrichshain Berlin, Germany
  • Klinikum Bielefeld Bielefeld, Germany
  • Städtisches Klinikum Dresden Dresden, Germany
View all 20 locations
View Trial Details
Recruiting

Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery

NCT03051464

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • UT Southwestern Medical Center Dallas, Texas, United States
  • Le Centre Hospitalier de l'Université de Montreal Montreal, Quebec, Canada
  • Jewish General Hospital Montreal, Quebec, Canada
  • Centre hospitalier universitaire de Québec Québec, Quebec, Canada
View Trial Details

Related conditions